DOJ Order Leaves tribal cannabis Programs Out
DOJ moved FDA-approved medical cannabis to Schedule III but omitted tribal cannabis programs, leaving questions on DEA registration, supply and tax policy.
Cannabis news, weed news, marijuana news
DOJ moved FDA-approved medical cannabis to Schedule III but omitted tribal cannabis programs, leaving questions on DEA registration, supply and tax policy.
Cannabis companies may not need to wait for federal rescheduling to escape the burdensome 280E tax penalties that prevent them…